Literature DB >> 12199829

Does marijuana use have residual adverse effects on self-reported health measures, socio-demographics and quality of life? A monozygotic co-twin control study in men.

Seth A Eisen1, Sunanta Chantarujikapong, Hong Xian, Michael J Lyons, Rosemary Toomey, William R True, Jeffrey F Scherrer, Jack Goldberg, Ming T Tsuang.   

Abstract

AIMS: To assess the effects of former heavy marijuana use on selected aspects of health.
DESIGN: A monozygotic co-twin control design was used to compare the health of former heavy marijuana using male monozygotic twins to that of their co-twins who never used marijuana significantly.
SETTING: In-person survey and questionnaires. PARTICIPANTS: Fifty-six marijuana use discordant monozygotic twin pair members of the Vietnam Era Twin (VET) Registry. MEASUREMENTS: Current socio-demographic characteristics; current nicotine and alcohol use; life-time nicotine and alcohol abuse/dependence; past 5-year physical and mental health services utilization; and health-related quality of life.
FINDINGS: The mean number of days on which the marijuana user twin used marijuana in his life-time was 1085, while the non-marijuana user used marijuana a maximum of 5 days. Marijuana was last used a mean of 20 years previously. No significant differences were found between the former marijuana user twins and their siblings for current socio-demographic characteristics; current nicotine or alcohol use; life-time nicotine or alcohol abuse/dependence; past 5-year out-patient or emergency room visits, hospitalizations or medication use for medical problems; past 5-year mental health out-patient use or hospitalizations; or health-related quality of life.
CONCLUSIONS: Previous heavy marijuana use a mean of 20 years earlier by a group of men who reported no other significant illicit drug use does not appear to be associated with adverse socio-demographic, physical or mental health adverse effects. The conclusions of the study are limited by possible participation and recall biases, relatively small sample size and the absence of a physical health examination.

Entities:  

Mesh:

Year:  2002        PMID: 12199829     DOI: 10.1046/j.1360-0443.2002.00120.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  6 in total

Review 1.  Cannabis use and cannabis use disorder.

Authors:  Jason P Connor; Daniel Stjepanović; Bernard Le Foll; Eva Hoch; Alan J Budney; Wayne D Hall
Journal:  Nat Rev Dis Primers       Date:  2021-02-25       Impact factor: 52.329

2.  The Cannabis Abuse Screening Test (CAST) revisited: examining measurement invariance by age.

Authors:  Sharon R Sznitman
Journal:  Int J Methods Psychiatr Res       Date:  2016-10-10       Impact factor: 4.035

3.  Lifetime substance misuse and 5-year incidence rates of emergent health problems among middle-aged adults.

Authors:  Kristin M Caspers; Rebecca Yucuis; Lowell M McKirgan; Ruth Spinks; Stephan Arndt
Journal:  J Addict Dis       Date:  2009-10

4.  A comparison of psychosocial and cognitive functioning between depressed and non-depressed patients with cannabis dependence.

Authors:  Alex M Secora; David Eddie; Bertram J Wyman; Daniel J Brooks; John J Mariani; Frances R Levin
Journal:  J Addict Dis       Date:  2010-07

Review 5.  Down and High: Reflections Regarding Depression and Cannabis.

Authors:  Catherine Langlois; Stéphane Potvin; Atul Khullar; Smadar Valérie Tourjman
Journal:  Front Psychiatry       Date:  2021-05-14       Impact factor: 4.157

6.  An Approach to Biomarker Discovery of Cannabis Use Utilizing Proteomic, Metabolomic, and Lipidomic Analyses.

Authors:  Jesse D Hinckley; Laura Saba; Kristen Raymond; Karsten Bartels; Jost Klawitter; Uwe Christians; Christian Hopfer
Journal:  Cannabis Cannabinoid Res       Date:  2020-06-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.